Clinic
Memorial Hermann Health System
Memorial Hermann Health System was paid $84.45M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 99284, emergency room visit (serious) — 53% of everything it billed.
33Billing provider infoMEMORIAL HERMANN HEALTH SYSTEM
HOUSTON, TX 77008
HOUSTON, TX 77008
33aNPI1730132234assigned 05/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$84.45M
24GClaims911,397
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#4 of 320
Median peer was paid$205K
This provider vs. median412×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,127 | $122K | |
| 2019 | 3,887 | $164K | |
| 2020 | 21,669 | $2.54M | |
| 2021 | 198,341 | $20.94M | |
| 2022 | 267,374 | $22.79M | |
| 2023 | 264,440 | $26.50M | |
| 2024incomplete | 153,559 | $11.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 53% | 87,609 | 83,037 | $44.36M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 20,721 | 19,263 | $9.57M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 69,464 | 67,584 | $8.50M |
| 80053 | Comprehensive metabolic panel | 3.0% | 48,926 | 44,444 | $2.50M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 103,588 | 90,625 | $2.35M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 22,866 | 21,120 | $2.14M |
| 71045 | Radiologic examination, chest; single view | 2.4% | 41,465 | 39,582 | $2.01M |
| 81001 | 1.8% | 64,376 | 60,809 | $1.51M | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 36,397 | 35,389 | $1.50M |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 37,147 | 31,083 | $1.19M |
| 87400 | 1.3% | 30,850 | 15,364 | $1.11M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 3,884 | 3,689 | $891K |
211 more codes
| 83690 | <1% | 15,161 | $404K | |
| 76801 | <1% | 3,755 | $388K | |
| 93975 | <1% | 1,825 | $365K | |
| 84484 | <1% | 17,170 | $336K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 5,657 | $322K |
| 84703 | <1% | 9,003 | $305K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,492 | $293K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,921 | $241K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 811 | $182K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,298 | $173K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,596 | $165K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,405 | $164K |
| 80076 | <1% | 8,749 | $163K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,180 | $155K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,279 | $144K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,041 | $132K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,084 | $116K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 389 | $105K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,674 | $103K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 15,082 | $99K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,289 | $96K |
| 87807 | <1% | 3,580 | $94K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,843 | $90K |
| 84702 | <1% | 6,041 | $90K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,381 | $88K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,242 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,269 | $72K |
| 84450 | <1% | 2,389 | $66K | |
| 84075 | <1% | 2,408 | $58K | |
| 76830 | Ultrasound, transvaginal | <1% | 614 | $57K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,517 | $53K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 698 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,431 | $49K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,174 | $48K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,752 | $48K |
| J3490 | Unclassified drugs | <1% | 6,662 | $48K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 585 | $46K |
| 83880 | <1% | 3,386 | $42K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 964 | $40K |
| 84145 | <1% | 3,222 | $39K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,247 | $38K |
| 82247 | <1% | 2,430 | $37K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 806 | $36K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 386 | $35K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,152 | $34K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,826 | $34K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 85 | $34K |
| 97162 | <1% | 1,092 | $33K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,199 | $32K |
| 82550 | <1% | 5,779 | $32K | |
| 93971 | <1% | 493 | $30K | |
| 84155 | <1% | 2,399 | $29K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 232 | $28K |
| 86850 | <1% | 3,323 | $27K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 493 | $27K |
| 59025 | Fetal non-stress test | <1% | 222 | $26K |
| 83605 | <1% | 4,293 | $21K | |
| 82803 | <1% | 1,938 | $20K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,051 | $20K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 271 | $20K |
| 85730 | <1% | 7,396 | $18K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 207 | $18K |
| 71250 | <1% | 501 | $18K | |
| 85610 | <1% | 8,573 | $17K | |
| 36000 | <1% | 1,745 | $17K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 45 | $16K |
| 96376 | <1% | 3,033 | $16K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 185 | $15K |
| 83735 | <1% | 5,776 | $15K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 937 | $15K |
| 82077 | <1% | 1,692 | $15K | |
| 81025 | <1% | 1,879 | $14K | |
| 97166 | <1% | 434 | $14K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,383 | $13K |
| 73562 | <1% | 792 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,049 | $13K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 170 | $12K |
| 70498 | <1% | 140 | $12K | |
| 70496 | <1% | 144 | $12K | |
| 87081 | <1% | 871 | $12K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 35 | $11K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,745 | $11K |
| 93970 | <1% | 104 | $10K | |
| 73030 | <1% | 666 | $10K | |
| 86900 | <1% | 6,067 | $10K | |
| 82040 | <1% | 2,344 | $10K | |
| 86901 | <1% | 6,058 | $10K | |
| 80143 | <1% | 1,015 | $9K | |
| 73630 | <1% | 554 | $9K | |
| 80179 | <1% | 974 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 200 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 376 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 368 | $8K |
| 87040 | <1% | 1,681 | $8K | |
| 74018 | <1% | 451 | $8K | |
| 70486 | <1% | 129 | $7K | |
| G0378 | Hospital observation service, per hour | <1% | 1,391 | $7K |
| 73502 | <1% | 359 | $6K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12 | $6K |
| 87186 | <1% | 1,868 | $6K | |
| 49083 | <1% | 22 | $5K | |
| 85379 | <1% | 974 | $5K | |
| 90715 | <1% | 314 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 531 | $5K |
| 76770 | <1% | 98 | $5K | |
| 73610 | <1% | 240 | $5K | |
| 97161 | <1% | 228 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 486 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,162 | $4K |
| 73130 | <1% | 174 | $4K | |
| 86923 | <1% | 465 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 78 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,654 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,300 | $3K |
| 87077 | <1% | 1,105 | $3K | |
| 80061 | Lipid panel | <1% | 850 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 951 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,494 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 940 | $3K |
| 72100 | <1% | 169 | $3K | |
| 74174 | <1% | 13 | $3K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 156 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,535 | $3K |
| 82248 | <1% | 381 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 473 | $2K |
| 82947 | <1% | 4,310 | $2K | |
| 97116 | <1% | 807 | $2K | |
| 76641 | <1% | 31 | $2K | |
| 84100 | <1% | 2,289 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,713 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 31 | $2K |
| 94760 | <1% | 531 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 730 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,513 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 30 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,903 | $2K |
| 72170 | <1% | 216 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,607 | $2K |
| 82140 | <1% | 419 | $2K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 72 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 3,637 | $1K |
| 96367 | <1% | 52 | $1K | |
| 73590 | <1% | 98 | $1K | |
| 84112 | <1% | 28 | $1K | |
| 77080 | <1% | 538 | $1K | |
| 73110 | <1% | 53 | $1K | |
| 82570 | <1% | 461 | $1K | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 621 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,346 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 114 | $1K |
| J1815 | Injection, insulin, per 5 units | <1% | 241 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,544 | $1K |
| 88342 | <1% | 90 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,133 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 724 | $994.63 |
| 87210 | <1% | 225 | $851.63 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $844.19 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 816 | $841.57 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,518 | $797.11 |
| 87340 | <1% | 531 | $758.40 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 48 | $751.88 |
| 85027 | <1% | 383 | $739.29 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 630 | $692.78 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 621 | $678.88 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 125 | $677.96 |
| 84156 | <1% | 396 | $668.78 | |
| 88304 | <1% | 13 | $562.48 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 901 | $497.15 |
| 72131 | <1% | 12 | $400.35 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 200 | $384.48 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 181 | $313.20 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 780 | $299.48 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 803 | $289.93 |
| 73560 | <1% | 17 | $289.53 | |
| 85014 | <1% | 702 | $272.79 | |
| 90662 | <1% | 53 | $265.38 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 29 | $182.04 |
| 85018 | <1% | 302 | $155.77 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 48 | $150.29 |
| 86140 | <1% | 82 | $146.04 | |
| 82565 | <1% | 122 | $145.20 | |
| 73090 | <1% | 13 | $135.38 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 134 | $121.61 |
| 90686 | <1% | 15 | $115.42 | |
| 88312 | <1% | 36 | $105.54 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 112 | $104.05 |
| 87147 | <1% | 27 | $98.83 | |
| 84132 | <1% | 298 | $94.80 | |
| 87070 | <1% | 79 | $91.81 | |
| 82728 | <1% | 28 | $87.59 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 13 | $73.04 |
| 87205 | <1% | 80 | $60.56 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $59.41 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 12 | $48.33 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | <1% | 17 | $40.77 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 14 | $39.88 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 18 | $25.92 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 13 | $23.62 |
| 36415 | Collection of venous blood by venipuncture | <1% | 420 | $22.13 |
| 82010 | <1% | 15 | $21.75 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 40 | $20.77 |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | <1% | 14 | $16.97 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 16 | $16.58 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 39 | $10.88 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 44 | $10.75 |
| 84439 | <1% | 12 | $7.58 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $4.23 |
| G0008 | Administration of influenza virus vaccine | <1% | 85 | $0.68 |
| C1769 | Guide wire | 0% | 105 | $0.00 |
| 80047 | 0% | 58 | $0.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARAWAY, DENNIS (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.